Foghorn’s AML/MDS Trial Moved From Partial To Full Clinical Hold

Uveal Melanoma Study Continues

 
• By Mandy Jackson
  
Innovation technology with security switch for information security management concept
Foghorn's Phase I trial of FHD-286 in AML/MDS is on a full clinical hold • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D